5th STING And TLR-Targeted Therapies Summit 2024
Evvnt Promotion / evvnt
19.06.2024 - 20.06.2024 Sheraton Mission Valley San Diego Hotel, 1433 Camino del Rio South, 92108 San Diego, California, USA
Time: 8:00 am to 4:30 pm
Temi della conferenza
The innate immune system is increasingly being recognised as a target for a range of exciting applications with high unmet need, from those difficult to treat cancers to infectious and inflammatory disease.
The past year has seen a mix of ups and downs for this space, with several companies entering the clinic, emerging new modalities of STING/TLR agonists and on the other side some clinical setbacks.
The innate immune system is increasingly being recognised as a target for a range of exciting applications with high unmet need, from those difficult to treat cancers to infectious and inflammatory disease.
The past year has seen a mix of ups and downs for this space, with several companies entering the clinic, emerging new modalities of STING/TLR agonists and on the other side some clinical setbacks.
Scientific organizer
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/2277808-3?pid=4832
Speakers: Aarron Willingham, Executive Director, Merck and Co, Anna Galkin, CSO, Axelia Oncology and more.
Brochure: https://go.evvnt.com/2277808-3?pid=4832
Speakers: Aarron Willingham, Executive Director, Merck and Co, Anna Galkin, CSO, Axelia Oncology and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/2277808-2?pid=4832
Ms. Abigail Cox
Servizi sanitari
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
